Get started
RepliCel Life Sciences Inc.RepliCel Life Sciences Inc.RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

REPCF chart

Key stats

Market capitalization
‪2.59 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
8.2109
Basic EPS (TTM)
0.0050USD
Net income
‪−548.28 K‬USD
Revenue
‪260.95 K‬USD
Shares float
‪23.06 M‬
Beta (1Y)
−0.13

About RepliCel Life Sciences Inc.

Sector
Health Technology
CEO
Andrew Schutte
Headquarters
Vancouver
Website
replicel.com
Founded
1967
ISIN
CA76027P4006
FIGI
BBG000PMW6N9
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of REPCF is 0.04 USD — it has increased by 4.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RepliCel Life Sciences Inc. stocks are traded under the ticker REPCF.
RepliCel Life Sciences Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track RepliCel Life Sciences Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, REPCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RepliCel Life Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
REPCF reached its all-time high on Aug 3, 2004 with the price of 339.00 USD, and its all-time low was 0.03 USD and was reached on Dec 5, 2023.
See other stocks reaching their highest and lowest prices.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RepliCel Life Sciences Inc. EBITDA is ‪−1.01 M‬ USD, and current EBITDA margin is −394.27%. See more stats in RepliCel Life Sciences Inc. financial statements.